Expert Profile

Share QR code Edit Profile

Merry Markham

Chief And Robert E. And Roselee S. Wheeler Professor Of Medicine

MD-HEMATOLOGY/ONCOLOGY | COLLEGE-MEDICINE

View:

Select
All (all in one) Research Terms and Keywords Background Publications Activities Co-Investigator Network Websites Contact

All
Research
Background
Publications
Activities
Network
Websites
Contact

Research Terms & Keywords

Research Terms

Clinical Oncology

Keywords

Cancer Communications Cervical Cancer Endometrial Cancer Gynecologic Cancer Ovarian Cancer Quality Of Care Social Media

Research Projects

Ends

Title

02-2025

NRG GY-014 NRG GY-014

01-2024

Using Electronic Health Records from a Large Clinical Data Research Network to Understand Cancer Burden and Cancer Risks Among Transgender and Gender Nonconforming (TGNC) Individuals Using Electronic Health Records from a Large Clinical Data Research Network to Understand Cancer Burden and Cancer Risks Among Transgender and Gender Nonconforming (TGNC) Individuals

09-2023

A Randomized Phase II Study Comparing Single-Agent Olaparib, Single Agent Cediranib, and the Combination of Cediranib/Olaparib in Women with Recurrent, Persistent or Metastatic Endometrial Cancer A Randomized Phase II Study Comparing Single-Agent Olaparib, Single Agent Cediranib, and the Combination of Cediranib/Olaparib in Women with Recurrent, Persistent or Metastatic Endometrial Cancer

06-2022

Florida Academic Cancer Center Alliance Seed Grants Florida Academic Cancer Center Alliance Seed Grants

06-2021

Florida Cancer ReTOOL Program for Underrepresented Minority Students Florida Cancer ReTOOL Program for Underrepresented Minority Students

08-2019

Florida Minority Cancer Research and Training Center: Feasibility Studies Florida Minority Cancer Research and Training Center: Feasibility Studies

08-2019

A Randomized Phase II/III study of the combination of Cediranib and Olaparib compared to Cediranib or Olaparib alone, or Standard of care chemotherapy in women with recurrent platinum-resistant or -refractory ovarian, fallopian tube, or primary peritoneal A Randomized Phase II/III study of the combination of Cediranib and Olaparib compared to Cediranib or Olaparib alone, or Standard of care chemotherapy in women with recurrent platinum-resistant or -refractory ovarian, fallopian tube, or primary peritoneal

06-2019

A Randomized Phase II Trial of Radiation Therapy and Cisplatin Alone or in Combination With Intravenous Triapine in Women With Newly Diagnosed Bulky Stage IB2, Stage II, IIIB, or IVA Cancer of the Uterine Cervix or Stage II-IVA Vaginal Cancer A Randomized Phase II Trial of Radiation Therapy and Cisplatin Alone or in Combination With Intravenous Triapine in Women With Newly Diagnosed Bulky Stage IB2, Stage II, IIIB, or IVA Cancer of the Uterine Cervix or Stage II-IVA Vaginal Cancer

03-2019

A RANDOMIZED PHASE II/III STUDY OF PACLITAXEL/CARBOPLATIN/METFORMIN (NSC#91485) VERSUS PACLITAXEL/CARBOPLATIN/PLACEBO AS INITIAL THERAPY FOR MEASURABLE STAGE III OR IVA, STAGE IVB, OR RECURRENT ENDOMETRIAL CANCER A RANDOMIZED PHASE II/III STUDY OF PACLITAXEL/CARBOPLATIN/METFORMIN (NSC#91485) VERSUS PACLITAXEL/CARBOPLATIN/PLACEBO AS INITIAL THERAPY FOR MEASURABLE STAGE III OR IVA, STAGE IVB, OR RECURRENT ENDOMETRIAL CANCER

02-2019

ET-CTN with Phase 2 Emphasis ET-CTN with Phase 2 Emphasis

02-2019

A Phase III study comparing single-agent olaparib or the combination of cediranib and olaparib to standard platinum-based chemotherapy in women with recurrent platinum-sensitive ovarian, fallopian tube, or primary peritoneal cancer A Phase III study comparing single-agent olaparib or the combination of cediranib and olaparib to standard platinum-based chemotherapy in women with recurrent platinum-sensitive ovarian, fallopian tube, or primary peritoneal cancer

02-2019

06-2018

ASCO-sponsored cancer interest group ASCO-sponsored cancer interest group

01-2018

A Randomized, Controlled, Open-Label, Phase 2 Trial of SGI-110 and Carboplatin in Subjects with Platinum-Resistant Recurrent Ovarian Cancer A Randomized, Controlled, Open-Label, Phase 2 Trial of SGI-110 and Carboplatin in Subjects with Platinum-Resistant Recurrent Ovarian Cancer

11-2012

FIQCC-P03 FIQCC-P03

06-2011

FIQCC-P02 FIQCC-P02

04-2010

Pain and Palliative Care Competency Training Pain and Palliative Care Competency Training

08-2009

FIQCC FIQCC

Degrees

M.D., Medicine

University of Miami Miller School of Medicine ▪ 2001

Publications

Search Google Scholar for Merry Markham

Memberships

American Society of Clinical Oncology, Member; 2005 - present

Co-Investigator Network

Linda Behar-Horenstein

Distinguished Teaching Scholar/Prof

University of Florida

PH-PHARMTHERAPY TRNSL RSCH, College-Pharmacy

Lsbhoren@ufl.edu

Kevin Brown

Associate Professor

University of Florida

MD-BIOCHEM / MOLECULAR BIOL, College-Medicine

kdbrown1@ufl.edu

Inactive Expert

Mary Burg

ASO PROF

University of Florida

MD-CHFM-GEN ADMINISTRATION, College-Medicine

burg@ufl.edu

Ronald Castellano

Assistant Professor

University of Florida

LS-CHEMISTRY-GENERAL, Clas

castellano@chem.ufl.edu

Linda Cottler

Dean's Professor of Epidemiology

University of Florida

PHHP-COM EPIDEMIOLOGY, Phhp-Com Integrated Programs

lbcottler@ufl.edu

Yehia Daaka

Professor and department chair

University of Florida

MD-ANATOMY, College-Medicine

ydaaka@ufl.edu

Vincent DeGennaro

University of Florida

LT-CTR-LT AMER STUDIES-ADMIN, Type One Centers

Thomas George

AssociateProfessor - Physician

University of Florida

MD-HEMATOLOGY/ONCOLOGY, College-Medicine

tgeorge@ufl.edu

Inactive Expert

Dawn Grinenko

Clinical Assistant Professor

University of Florida

MD-CHFM-GEN ADMINISTRATION, College-Medicine

grinedm@ufl.edu

Yi Guo

Associate Professor

University of Florida

MD-HOBI-GENERAL, College-Medicine

yiguo@ufl.edu

Inactive Expert

Nancy Hardt, MD

Director Health Disparities and Service Learning Programs

University of Florida

MD-PATHOLOGY-GENERAL, College-Medicine

hardt@pathology.ufl.edu

Inactive Expert

Amanda Hicks

Assistant Professor

University of Florida

DEPARTMENT OF HEALTH OUTCOMES AND BIOMEDICAL INFORMATICS, College-Medicine

aehicks@ufl.edu

Suming Huang

University of Florida

MD-BIOCHEMISTRY-GENERAL, College-Medicine

sumingh@ufl.edu

Christian Jobin

Professor of Medicine; Principal Investigator

University of Florida

MD-GASTROENTEROLOGY, College-Medicine

cjobin@ufl.edu

Frederic Kaye

Professor

University of Florida

MD-HEMATOLOGY/ONCOLOGY, College-Medicine

fkaye@ufl.edu

Michael Kladde

Professor & Director of Center for Epigenetics

University of Florida

MD-BIOCHEM / MOLECULAR BIOL, College-Medicine

kladde@ufl.edu

Brian Law

Associate Professor

University of Florida

MD-PHARMACOLOGY / THERAPEUTICS, College-Medicine

bklaw@ufl.edu

Tanmay Lele

Faculty

University of Florida

MD-ANATOMY-GENERAL, College-Medicine

tlele@che.ufl.edu

Jonathan Licht

UF Health Cancer Center Director and The Marshall E. Rinker Senior Chair

University of Florida

MD-HEMATOLOGY/ONCOLOGY-ONCOL, College-Medicine

jdlicht@ufl.edu

Debra Lyon

Interim Dean, Executive Aso Dean & Kirbo Endowed Chair

University of Florida

NR-DEAN-ADMINISTRATION, College-Nursing

delyon@ufl.edu

Nancy Mendenhall

Professor and Associate Chair

University of Florida

MD-RADIATION ONCOLOGY, College-Medicine

menden@shands.ufl.edu

David Nelson

Senior Vice President for Health Affairs, UF & President, UF Health

University of Florida

HA-EXECUTIVE, Office Of Health Affairs

nelsodr@ufl.edu

Walter O'Dell

Associate Professor

University of Florida

MD-RADIATION ONCOLOGY, College-Medicine

odelwg@shands.ufl.edu

Folakemi Odedina

Professor

University of Florida

PH-PHARMTHERAPY TRNSL RSCH, College-Pharmacy

fodedina@cop.ufl.edu

Mattia Prosperi

Professor and Associate Dean for AI and Innovation

University of Florida

HP-OFFICE OF THE DEAN, College-Publ Hlth / Hlth Profs

m.prosperi@ufl.edu

Rolf Renne

Professor

University of Florida

MD-MOLECULAR GENTCS / MICROBIO, College-Medicine

rrenne@ufl.edu

Carlos Rinaldi

University of Florida

EG-CHEMICAL ENGINEERING, College-Engineering

carlos.rinaldi@ufl.edu

Elias Sayour

Assistant Professor

University of Florida

MD-NEUROLOGICAL SURGERY, College-Medicine

elias.sayour@neurosurgery.ufl.edu

Richard Segal

PROF & CHR

University of Florida

PH-PHARM OUTCOMES & POLICY, College-Pharmacy

segal@cop.ufl.edu

Elizabeth Shenkman

Professor and Chair

University of Florida

MD- Health Outcomes and Policy, College-Medicine

eas@ichp.ufl.edu

Dietmar Siemann

Professor; Associate Director for Education and Training, UFHCC

University of Florida

MD-RADIATION ONCOLOGY, College-Medicine

siemadw@ufl.edu

Lindsay Thompson

Professor and Medical Director, Pediatric Research Hub

University of Florida

MD-PEDS-ADMINISTRATION, College-Medicine

lathompson@peds.ufl.edu

Jose Trevino

Associate Professor

University of Florida

MD-SURGERY-SURGONC-PBS, College-Medicine

trevinojg@ufl.edu

Diana Wilkie

Professor

University of Florida

NR-BNS-BIOBEHAVORIAL NUR SCI, College-Nursing

diwilkie@ufl.edu

Inactive Expert

Lusine Yaghjyan

University of Florida

PHHP-COM EPIDEMIOLOGY, Phhp-Com Integrated Programs

lyaghjyan@ufl.edu

Inactive Expert

Mary Young

Clinical Associate Professor

University of Florida

HP-BEHAVIORAL SCI COMM HLTH, College-Publ Hlth / Hlth Profs

meyoung@phhp.ufl.edu

Websites

0000-0003-3567-3494

Search Google Scholar for Merry Markham

twitter

Contact Information

merry.markham@medicine.ufl.edu

3522737832

PO Box 100278
GAINESVILLE, FL 32610-0278

Profile QR code

What is this?

Merry Markham

Chief And Robert E. And Roselee S. Wheeler Professor Of Medicine

MD-HEMATOLOGY/ONCOLOGY | COLLEGE-MEDICINE

Research Terms & Keywords

Research Projects

Degrees

Publications

Memberships

Co-Investigator Network

Websites

Contact Information

About

Discover

Connect

Keyword Search

Browse by STEM